Sartorius Stedim Biotech Updates on Shares and Voting Rights

Sartorius Stedim Biotech SA released a statement concerning its issued capital's share and voting rights as of October 31, 2026. The company, headquartered in Aubagne, France, reported a total of 97,330,405 shares comprising its issued capital. The announcement further detailed the number of theoretical voting rights, totaling 164,924,442, which includes treasury shares. The net voting rights are reported at 164,903,992.

This update aligns with Article L 233-8-II of the French Code of Commerce and Article 223-6 of the AMF's general regulations. The company disseminated this regulatory news through EQS Group, ensuring transparency and compliance with regulatory requirements.